The approval of Biogen Idec’s MS therapy Tecfidera follows months of breathless Wall Street hype, and it looks like doctors are psyched for the drug, too. In a MedLIVE PULSE survey conducted by WorldOne...
CompanyBriefs
Apr 02, 2013
» A half dozen electronic health record vendors have formed a non-profit organization called the Commonwell Health Alliance. The organization’s goal is to create a national infrastructure with common...
FDA wants lower doses for sleeping aids
By
Elizabeth Newman
Feb 01, 2013
The Food and Drug Administration is requiring manufacturers of certain sleeping pills, including the widely prescribed Ambien, to reduce current recommended dosages.
Groups blast new IRS device tax rules
By
John O'Connor
Jan 02, 2013
Internal Revenue Service guidance released in December spells out how a 2.3% excise tax on medical devices would be carried out.
Drug pipelines far from full, report finds
By
McKnight's Staff
Oct 01, 2012
With new and novel medicines launched the last couple of years for diseases such as cancer, hepatitis C virus and multiple sclerosis, one would think that pharmaceutical pipelines are gradually improving....
Failures halt Phase III trials of infused Alzheimer’s drug
By
Deborah Weinstein
Sep 01, 2012
Pfizer, Johnson & Johnson, and Elan said all Phase III tests of Alzheimer’s drug bapineuzumab are being halted after the drug failed to hit its goals for cognition and global function.
GE, Microsoft to launch health data firm
By
John O'Connor
Feb 01, 2012
Microsoft announced that it will partner with General Electric to form a new company that makes healthcare information more accessible. The partners said they hope to optimize the treatment that healthcare...
Omnicare extends PharMerica buy offer
By
John O'Connor
Jan 03, 2012
Pharmacy giant Omnicare announced that it was extending to Jan. 20 its offer to purchase all outstanding shares of rival PharMerica for $15 per share. The original offer had been scheduled to expire in...